Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Evaluation and Management of Congenital Chagas Disease in the United States.

Edwards MS, Stimpert KK, Bialek SR, Montgomery SP.

J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):461-469. doi: 10.1093/jpids/piz018.

PMID:
31016324
2.

Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening.

Stillwaggon E, Perez-Zetune V, Bialek SR, Montgomery SP.

Am J Trop Med Hyg. 2018 Jun;98(6):1733-1742. doi: 10.4269/ajtmh.17-0818. Epub 2018 Apr 26.

3.

Hearing Trajectory in Children with Congenital Cytomegalovirus Infection.

Lanzieri TM, Chung W, Leung J, Caviness AC, Baumgardner JL, Blum P, Bialek SR, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Otolaryngol Head Neck Surg. 2018 Apr;158(4):736-744. doi: 10.1177/0194599818758247. Epub 2018 Mar 20.

4.

Urinary Cytomegalovirus Shedding in the United States: The National Health and Nutrition Examination Surveys, 1999-2004.

Amin MM, Bialek SR, Dollard SC, Wang C.

Clin Infect Dis. 2018 Aug 1;67(4):587-592. doi: 10.1093/cid/ciy143.

5.

Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.

Lopez AS, Lanzieri TM, Claussen AH, Vinson SS, Turcich MR, Iovino IR, Voigt RG, Caviness AC, Miller JA, Williamson WD, Hales CM, Bialek SR, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Pediatrics. 2017 Nov;140(5). pii: e20171517. doi: 10.1542/peds.2017-1517.

6.

Long-term outcomes of children with symptomatic congenital cytomegalovirus disease.

Lanzieri TM, Leung J, Caviness AC, Chung W, Flores M, Blum P, Bialek SR, Miller JA, Vinson SS, Turcich MR, Voigt RG, Demmler-Harrison G.

J Perinatol. 2017 Jul;37(7):875-880. doi: 10.1038/jp.2017.41. Epub 2017 Apr 6.

7.

Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection.

Lanzieri TM, Chung W, Flores M, Blum P, Caviness AC, Bialek SR, Grosse SD, Miller JA, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Pediatrics. 2017 Mar;139(3). pii: e20162610. doi: 10.1542/peds.2016-2610. Epub 2017 Feb 16.

8.

Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China.

Wang S, Wang T, Zhang W, Liu X, Wang X, Wang H, He X, Zhang S, Xu S, Yu Y, Jia X, Wang M, Xu A, Ma W, Amin MM, Bialek SR, Dollard SC, Wang C.

Medicine (Baltimore). 2017 Feb;96(5):e6007. doi: 10.1097/MD.0000000000006007.

9.

Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010.

Civen R, Marin M, Zhang J, Abraham A, Harpaz R, Mascola L, Bialek SR.

Pediatr Infect Dis J. 2016 Oct;35(10):1132-6. doi: 10.1097/INF.0000000000001249.

PMID:
27622686
10.

What Do We Know About Chagas Disease in the United States?

Montgomery SP, Parise ME, Dotson EM, Bialek SR.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1225-1227. doi: 10.4269/ajtmh.16-0213. Epub 2016 Jul 11.

11.

Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20-49 years in the USA.

Lanzieri TM, Kruszon-Moran D, Gambhir M, Bialek SR.

Int J Gynaecol Obstet. 2016 Oct;135(1):82-5. doi: 10.1016/j.ijgo.2016.03.032. Epub 2016 Jun 29.

12.

Risk Factors for Herpes Zoster Among Adults.

Marin M, Harpaz R, Zhang J, Wollan PC, Bialek SR, Yawn BP.

Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119. doi: 10.1093/ofid/ofw119. eCollection 2016 Sep.

13.

Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care-based studies.

Hales CM, Harpaz R, Bialek SR.

Ann Epidemiol. 2016 Jun;26(6):441-446.e3. doi: 10.1016/j.annepidem.2016.04.006. Epub 2016 Apr 13.

14.

Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States.

Wang C, Dollard SC, Amin MM, Bialek SR.

PLoS One. 2016 Mar 18;11(3):e0151996. doi: 10.1371/journal.pone.0151996. eCollection 2016.

15.

Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Perella D, Wang C, Civen R, Viner K, Kuguru K, Daskalaki I, Schmid DS, Lopez AS, Tseng HF, Newbern EC, Mascola L, Bialek SR.

Pediatrics. 2016 Apr;137(4). pii: e20152802. doi: 10.1542/peds.2015-2802. Epub 2016 Mar 14.

16.

Varicella immunization requirements for US colleges: 2014-2015 academic year.

Leung J, Marin M, Leino V, Even S, Bialek SR.

J Am Coll Health. 2016 Aug-Sep;64(6):490-5. doi: 10.1080/07448481.2016.1138481. Epub 2016 Jan 30.

17.

Impact of the US Two-dose Varicella Vaccination Program on the Epidemiology of Varicella Outbreaks: Data from Nine States, 2005-2012.

Leung J, Lopez AS, Blostein J, Thayer N, Zipprich J, Clayton A, Buttery V, Andersen J, Thomas CA, Del Rosario M, Seetoo K, Woodall T, Wiseman R, Bialek SR.

Pediatr Infect Dis J. 2015 Oct;34(10):1105-9. doi: 10.1097/INF.0000000000000821.

18.

Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010.

Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS, McLean HQ.

Open Forum Infect Dis. 2015 Feb 20;2(1):ofv006. doi: 10.1093/ofid/ofv006. eCollection 2015 Jan.

19.

Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.

Marin M, Yawn BP, Hales CM, Wollan PC, Bialek SR, Zhang J, Kurland MJ, Harpaz R.

Hum Vaccin Immunother. 2015;11(5):1157-64. doi: 10.1080/21645515.2015.1016681.

20.

Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.

Leung J, Bialek SR, Marin M.

Hum Vaccin Immunother. 2015;11(3):662-8. doi: 10.1080/21645515.2015.1008880.

21.

An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.

Doll MK, Rosen JB, Bialek SR, Szeto H, Zimmerman CM.

Am J Public Health. 2015 May;105(5):972-9. doi: 10.2105/AJPH.2014.302229. Epub 2014 Dec 18.

22.

Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012.

Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Carroll MD, Dollard SC.

Clin Vaccine Immunol. 2015 Feb;22(2):245-7. doi: 10.1128/CVI.00697-14. Epub 2014 Dec 17.

23.

Clinical inquiries regarding Ebola virus disease received by CDC--United States, July 9-November 15, 2014.

Karwowski MP, Meites E, Fullerton KE, Ströher U, Lowe L, Rayfield M, Blau DM, Knust B, Gindler J, Van Beneden C, Bialek SR, Mead P, Oster AM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1175-9.

24.

Challenges with controlling varicella in prison settings: experience of California, 2010 to 2011.

Leung J, Lopez AS, Tootell E, Baumrind N, Mohle-Boetani J, Leistikow B, Harriman KH, Preas CP, Cosentino G, Bialek SR, Marin M.

J Correct Health Care. 2014 Oct;20(4):292-301. doi: 10.1177/1078345814541535. Epub 2014 Sep 7.

25.

Closure of varicella-zoster virus-containing vaccines pregnancy registry - United States, 2013.

Marin M, Willis ED, Marko A, Rasmussen SA, Bialek SR, Dana A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Aug 22;63(33):732-3.

26.

Update on recommendations for use of herpes zoster vaccine.

Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Aug 22;63(33):729-31.

27.

Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.

Thomas CA, Shwe T, Bixler D, del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR.

Pediatr Infect Dis J. 2014 Nov;33(11):1164-8. doi: 10.1097/INF.0000000000000444.

28.

Congenital cytomegalovirus-related hospitalizations in infants <1 year of age, United States, 1997-2009.

Lopez AS, Ortega-Sanchez IR, Bialek SR.

Pediatr Infect Dis J. 2014 Nov;33(11):1119-23. doi: 10.1097/INF.0000000000000421.

29.

Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.

Lanzieri TM, Bialek SR, Ortega-Sanchez IR, Gambhir M.

Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014. Epub 2014 May 14.

30.

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014.

Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, Best S, Blackmore C, Breakwell L, Cannons A, Brown C, Cetron M, Chea N, Chommanard C, Cohen N, Conover C, Crespo A, Creviston J, Curns AT, Dahl R, Dearth S, DeMaria A, Echols F, Erdman DD, Feikin D, Frias M, Gerber SI, Gulati R, Hale C, Haynes LM, Heberlein-Larson L, Holton K, Ijaz K, Kapoor M, Kohl K, Kuhar DT, Kumar AM, Kundich M, Lippold S, Liu L, Lovchik JC, Madoff L, Martell S, Matthews S, Moore J, Murray LR, Onofrey S, Pallansch MA, Pesik N, Pham H, Pillai S, Pontones P, Pringle K, Pritchard S, Rasmussen S, Richards S, Sandoval M, Schneider E, Schuchat A, Sheedy K, Sherin K, Swerdlow DL, Tappero JW, Vernon MO, Watkins S, Watson J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 May 16;63(19):431-6. Erratum in: MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):554.

31.

Links between herpes zoster incidence and childhood varicella vaccination.

Hales CM, Harpaz R, Bialek SR.

Ann Intern Med. 2014 Apr 15;160(8):582-3. doi: 10.7326/L14-5008-6. No abstract available.

32.

Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.

Lanzieri TM, Dollard SC, Bialek SR, Grosse SD.

Int J Infect Dis. 2014 May;22:44-8. doi: 10.1016/j.ijid.2013.12.010. Epub 2014 Mar 12. Review.

33.

Two-dose varicella vaccination coverage among children aged 7 years--six sentinel sites, United States, 2006-2012.

Lopez AS, Cardemil C, Pabst LJ, Cullen KA, Leung J, Bialek SR; Division of Viral Diseases; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 28;63(8):174-7.

34.

Notes from the field: varicella-associated death of a vaccinated child with leukemia - California, 2012.

Kriner P, Lopez K, Leung J, Harpaz R, Bialek SR; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 21;63(7):161.

35.

Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010.

Lanzieri TM, Bialek SR, Bennett MV, Gould JB.

J Perinat Med. 2014 May;42(3):393-9. doi: 10.1515/jpm-2013-0183.

36.

Examination of links between herpes zoster incidence and childhood varicella vaccination.

Hales CM, Harpaz R, Joesoef MR, Bialek SR.

Ann Intern Med. 2013 Dec 3;159(11):739-45. doi: 10.7326/0003-4819-159-11-201312030-00006.

37.

Seroprevalence of varicella-zoster virus in five US-bound refugee populations.

Leung J, Lopez A, Mitchell T, Weinberg M, Lee D, Thieme M, Schmid DS, Bialek SR.

J Immigr Minor Health. 2015 Feb;17(1):310-3. doi: 10.1007/s10903-013-9946-x.

38.

Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands.

Stowell JD, Forlin-Passoni D, Radford K, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS.

Appl Environ Microbiol. 2014 Jan;80(2):455-61. doi: 10.1128/AEM.03262-13. Epub 2013 Nov 1.

39.

Priorities for CMV vaccine development.

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA.

Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13. Review.

40.

Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, Lopez AS, Watson B, Civen R.

Pediatrics. 2013 Nov;132(5):e1134-40. doi: 10.1542/peds.2013-0863. Epub 2013 Oct 7.

41.

Fatal varicella due to the vaccine-strain varicella-zoster virus.

Leung J, Siegel S, Jones JF, Schulte C, Blog D, Schmid DS, Bialek SR, Marin M.

Hum Vaccin Immunother. 2014;10(1):146-9. doi: 10.4161/hv.26200. Epub 2013 Aug 27.

42.

Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.

Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M.

J Infect Dis. 2013 Dec 1;208(11):1859-68. doi: 10.1093/infdis/jit405. Epub 2013 Aug 6.

PMID:
23922376
43.

Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.

Mahamud A, Leung J, Masunu-Faleafaga Y, Teshale E, Williams R, Dulski T, Thieme M, Garcia P, Schmid DS, Bialek SR.

Epidemiol Infect. 2014 May;142(5):1002-7. doi: 10.1017/S095026881300174X. Epub 2013 Jul 26.

44.

Single-dose varicella vaccine effectiveness in school settings in China.

Wang Z, Yang H, Li K, Zhang A, Feng Z, Seward JF, Bialek SR, Wang C.

Vaccine. 2013 Aug 20;31(37):3834-8. doi: 10.1016/j.vaccine.2013.06.075. Epub 2013 Jul 8.

45.
46.

Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants.

Lanzieri TM, Dollard SC, Josephson CD, Schmid DS, Bialek SR.

Pediatrics. 2013 Jun;131(6):e1937-45. doi: 10.1542/peds.2013-0076. Epub 2013 May 27. Review. Erratum in: Pediatrics. 2014 Apr;133(4):755.

47.

Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data.

Leung J, Cannon MJ, Grosse SD, Bialek SR.

BMC Infect Dis. 2012 Dec 3;12:334. doi: 10.1186/1471-2334-12-334.

48.

Chronic medical conditions as risk factors for herpes zoster.

Joesoef RM, Harpaz R, Leung J, Bialek SR.

Mayo Clin Proc. 2012 Oct;87(10):961-7. doi: 10.1016/j.mayocp.2012.05.021.

49.

Challenges in confirming a varicella outbreak in the two-dose vaccine era.

Mahamud A, Wiseman R, Grytdal S, Basham C, Asghar J, Dang T, Leung J, Lopez A, Schmid DS, Bialek SR.

Vaccine. 2012 Nov 6;30(48):6935-9. doi: 10.1016/j.vaccine.2012.07.076. Epub 2012 Aug 8.

PMID:
22884663
50.

Herpes zoster-related deaths in the United States: validity of death certificates and mortality rates, 1979-2007.

Mahamud A, Marin M, Nickell SP, Shoemaker T, Zhang JX, Bialek SR.

Clin Infect Dis. 2012 Oct;55(7):960-6. doi: 10.1093/cid/cis575. Epub 2012 Jun 19.

PMID:
22715169

Supplemental Content

Loading ...
Support Center